63006-93-9 Usage
Description
1,2,3,4-Tetrahydroisoquinoline-3-methanol, with the CAS number 63006-93-9, is a light orange solid compound that is useful in organic synthesis. It belongs to the class of tetrahydroisoquinolines, which are known for their diverse range of applications in various industries due to their unique chemical properties.
Uses
Used in Organic Synthesis:
1,2,3,4-Tetrahydroisoquinoline-3-methanol is used as a synthetic building block for the creation of various organic compounds. Its unique structure allows it to be a versatile starting material for the synthesis of a wide range of molecules, including pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
1,2,3,4-Tetrahydroisoquinoline-3-methanol is used as an intermediate in the synthesis of various pharmaceutical compounds. Its ability to be modified and functionalized makes it a valuable component in the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 1,2,3,4-Tetrahydroisoquinoline-3-methanol is used as a key component in the development of new pesticides, herbicides, and other crop protection agents. Its unique chemical properties enable the creation of novel molecules with improved efficacy and selectivity.
Used in Dye and Pigment Industry:
1,2,3,4-Tetrahydroisoquinoline-3-methanol is used as a precursor in the synthesis of dyes and pigments due to its light orange solid appearance. Its chemical structure can be modified to produce a variety of colors, making it a valuable asset in the development of new dyes and pigments for various applications, such as textiles, plastics, and inks.
Used in Research and Development:
1,2,3,4-Tetrahydroisoquinoline-3-methanol is also used in research and development laboratories as a model compound for studying various chemical reactions and mechanisms. Its unique structure and properties make it an ideal candidate for exploring new synthetic routes and understanding the reactivity of related compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 63006-93-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,0,0 and 6 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 63006-93:
(7*6)+(6*3)+(5*0)+(4*0)+(3*6)+(2*9)+(1*3)=99
99 % 10 = 9
So 63006-93-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H13NO/c12-7-10-5-8-3-1-2-4-9(8)6-11-10/h1-4,10-12H,5-7H2
63006-93-9Relevant articles and documents
STEREOCHEMICAL ASPECTS OF PHOTO-SET INDUCED DIRADICAL CYCLIZATION REACTIONS AS A PART OF ISOQUINOLINE ALAKALOID SYNTHETIC STRATEGIES
Cho, In-Seop,Lee, Chao-Pin,Mariano, Patrick S.
, p. 799 - 802 (1989)
Studies of the photo-SET induced cyclization reactions of an N-silylbenzyldihydroisoquinolinium salt have uncovered a potentially interesting feature governing stereoselectivities of diradical cyclization reactions.
(η5-Pentamethylcyclopentadienyl)iridium Complex Catalyzed Imine Reductions Utilizing the Biomimetic 1,4-NAD(P)H Cofactor and N-Benzyl-1,4-dihydronicotinamide as the Hydride-Transfer Agent
Soetens, Mathieu,Drouet, Fleur,Riant, Olivier
, p. 929 - 933 (2017/03/27)
The interaction between synthetic organometallic complexes and metabolic cofactors has proven to be a newly emerging topic in bioorganometallic chemistry. Thus, the first cationic Cp*Ir-catalyzed (Cp=η5-pentamethylcyclopentadienyl) imine reduction in neutral buffered aqueous medium was examined. The reaction was found to proceed through hydride transfer from NADH as the hydride source at room temperature in air. Cationic Cp*Ir complexes proved to be the most efficient catalysts for this transformation. We also highlighted that the choice of the proton source was essential. The method was subsequently applied to cyclic and noncyclic imines. Eventually, the concept was extended to the reductive alkylation of one amine.
MODULATORS OF REV-ERB
-
Page/Page column 63, (2015/07/16)
The subject matter herein concerns the identification and development of potent synthetic REV-ERB ligands, such as in vivo agonists and antagonists. These compounds allow for characterization of the effects of modulation of this receptor in vivo specifically on circadian behavior and metabolism, and have suitable characteristics for development of medicinal compounds useful for treatment of malconditions such as diabetes, obesity, atherosclerosis, dyslipidemia, a circadian rhythm disorder, coronary artery disease, bipolar disorder, depression, cancer, a sleep disorder, an anxiety disorder, an addiction disorder, a bone-related disorder such osteoporosis, a skeletal muscle disease, e.g., with compromised exercise capacity, or an autoimmune disorder such as psoriasis, multiple sclerosis, inflammatory bowel disease, and others.
